Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
Clinical Infectious Diseases2003Vol. 37(5), pp. 613–627
Citations Over TimeTop 1% of 2003 papers
Michael P. Dubé, James H. Stein, Judith A. Aberg, Carl J. Fichtenbaum, John G. Gerber, Karen T. Tashima, W. Keith Henry, Judith S. Currier, Dennis L. Sprecher, Marshall J. Glesby
Abstract
Michael P. Dube, James H. Stein, Judith A. Aberg, Carl J. Fichtenbaum, John G. Gerber, Karen T. Tashima, W. Keith Henry, Judith S. Currier, Dennis Sprecher, and Marshall J. Glesby, for the Adult AIDS Clinical Trials Group Cardiovascular Subcommittee Indiana University, Indianapolis; University of Wisconsin, Madison; Washington University, St. Louis, Missouri; University of Cincinnati and Cleveland Clinic, Ohio; University of Colorado, Denver; Brown University, Providence, Rhode Island; University of Minnesota, St. Paul; University of California at Los Angeles; and Cornell University, New York, New York
Related Papers
- → Lipid Management in Patients Who Have HIV and Are Receiving HIV Therapy(2009)35 cited
- → Dyslipidemia in HIV patients.(2005)22 cited
- → Switching Antiretroviral Therapy to Minimize Metabolic Complications(2010)13 cited
- → Dyslipidemia among HIV-positive children receiving antiretroviral therapy in Indonesia(2021)2 cited
- → Analysis for metabolic abnormalities associated with antiretroviral therapy in Japanese patients with human immunodeficiency virus-1 infection(2017)